Cargando…
Strategies to Re-Sensitize Castration-Resistant Prostate Cancer to Antiandrogen Therapy
Since prostate cancer (PCa) was described as androgen-dependent, the androgen receptor (AR) has become the mainstay of its systemic treatment: androgen deprivation therapy (ADT). Although, through recent years, more potent drugs have been incorporated, this chronic AR signaling inhibition inevitably...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135790/ https://www.ncbi.nlm.nih.gov/pubmed/37189723 http://dx.doi.org/10.3390/biomedicines11041105 |